CompletedNCT01404208
D-Cycloserine or Placebo Alongside CBT for Childhood OCD
About this title
2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD
Read the official source — NCT01404208Medication studyAges 7–17United States
Understand this study
Who was this study for?
Listed age limits: 7 years to 17 years.
- Listed locations
- BostonSee all locations and recruitment
Study information
Study start dateJuly 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 206
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 7 Years to 17 Years
- Official registry ID
- NCT01404208
- Official title
Show the full official title
2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD
Get this study by email
Recruitment & locations
CompletedBoston
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including D-Cycloserine and Placebo.
Who was this study for?
Listed age limits: 7 years to 17 years.
